On Tuesday, Sagimet Biosciences Inc (NASDAQ: SGMT) was -3.69% drop from the session before settling in for the closing price of $6.24. A 52-week range for SGMT has been $1.73 – $11.41.
Healthcare Sector giant saw their annual sales slid by -16.85% over the last five years. When this article was written, the company’s average yearly earnings per share was at -16.36%. With a float of $26.33 million, this company’s outstanding shares have now reached $31.00 million.
The firm has a total of 14 workers. Let’s measure their productivity.
Sagimet Biosciences Inc (SGMT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sagimet Biosciences Inc stocks. The insider ownership of Sagimet Biosciences Inc is 19.03%, while institutional ownership is 32.77%. The most recent insider transaction that took place on Nov 20 ’25, was worth 289,979. In this transaction Executive Chairman of this company sold 37,688 shares at a rate of $7.69, taking the stock ownership to the 81,005 shares. Before that another transaction happened on Nov 20 ’25, when Company’s Director proposed sale 37,688 for $7.85, making the entire transaction worth $295,851.
Sagimet Biosciences Inc (SGMT) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.5 earnings per share (EPS) during the time that was better than consensus figure (set at -0.59) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -16.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.25% during the next five years compared to -16.85% drop over the previous five years of trading.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
You can see what Sagimet Biosciences Inc (SGMT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Analysing the last 5-days average volume posted by the [Sagimet Biosciences Inc, SGMT], we can find that recorded value of 0.89 million was lower than the volume posted last year of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 35.34%.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 5.70%, which indicates a significant decrease from 21.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was lower than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.26, while its 200-day Moving Average is $6.34. Now, the first resistance to watch is $6.19. This is followed by the second major resistance level at $6.38. The third major resistance level sits at $6.51. If the price goes on to break the first support level at $5.87, it is likely to go to the next support level at $5.74. Now, if the price goes above the second support level, the third support stands at $5.55.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
There are 32,522K outstanding shares of the company, which has a market capitalization of 186.32 million. As of now, sales total 0 K while income totals -45,570 K. Its latest quarter income was 0 K while its last quarter net income were -12,910 K.
